Thomas Stöhr (Thomas Stoehr)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Blood Brain Barrier

Top Venues

Current drug metabolism

British journal of clinical pharmacology

Journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Wolfgang Schmalix, Karl-Uwe Petersen, Marija Pesic, Thomas Stöhr
The Metabolism of the New Benzodiazepine Remimazolam. Current drug metabolism (2024)
Karl-Uwe Petersen, Wolfgang Schmalix, Marija Pesic, Thomas Stöhr
Drug-Drug Interaction Potential of Remimazolam Mediated by CYP 450, Transporters, and Protein Binding. Current drug metabolism (2024)
Wolfgang Schmalix, Karl-Uwe Petersen, Marija Pesic, Thomas Stöhr
The Metabolism of the New Benzodiazepine Remimazolam. Current drug metabolism 25 (2) (2024)
Wolfgang Schmalix, Karl-Uwe Petersen, Marija Pesic, Thomas Stöhr
The Metabolism of the New Benzodiazepine Remimazolam. Current drug metabolism (2024)
Karl-Uwe Petersen, Wolfgang Schmalix, Marija Pesic, Thomas Stöhr
Carboxylesterase 1-Based Drug-Drug Interaction Potential of Remimazolam: In-Vitro Studies and Literature Review. Current drug metabolism (2024)
Robert B Kleiman, Borje Darpo, Michael Thorn, Thomas Stöhr, Frank Schippers
Potential strategy for assessing QT/QTc interval for drugs that produce rapid changes in heart rate: Electrocardiographic assessment of the effects of intravenous remimazolam on cardiac repolarization. British journal of clinical pharmacology 86 (8) (2020)
Frank Schippers, Marija Pesic, Robert Saunders, Keith Borkett, Shawn Searle, Lynn Webster, Thomas Stöhr
Randomized Crossover Trial to Compare Abuse Liability of Intravenous Remimazolam Versus Intravenous Midazolam and Placebo in Recreational Central Nervous System Depressant Users. Journal of clinical pharmacology 60 (9) (2020)